Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Silvia Mezi
Observed names:
MEZI, Silvia,
Mezi, Silvia,
S Mezi,
S. Mezi,
SILVIA MEZI
Institution:
Sapienza University of Rome
Observed institutions:
The University of Queensland,
Policlinico Umberto I,
University of Naples Federico II,
Sapienza University of Rome
ORCID:
0000-0003-4746-2678
Observed ORCID:
0000-0003-4746-2678
OpenAlex ID:
A5032411611
FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study
2015
·
Chiara Cremolini
, Fotios Loupakis
, et al.
·
The Lancet Oncology
·
1,195
Anti–PD-1 and Anti–PD-L1 in Head and Neck Cancer: A Network Meta-Analysis
2021
·
Andrea Botticelli
, Alessio Cirillo
, et al.
·
Frontiers in Immunology
·
114
PDF
Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy
2013
·
Roberto Iacovelli
, Antonella Palazzo
, et al.
·
British Journal of Clinical Pharmacology
·
85
PDF
Tobacco, Alcohol and Family History of Cancer as Risk Factors of Oral Squamous Cell Carcinoma: Case-Control Retrospective Study
2020
·
Gianluca Tenore
, Alessandro Nuvoli
, et al.
·
Applied Sciences
·
72
PDF
Incidence and risk of pulmonary toxicity in patients treated with mTOR inhibitors for malignancy. A meta-analysis of published trials
2012
·
Roberto Iacovelli
, Antonella Palazzo
, et al.
·
Acta Oncologica
·
72
PDF
The Agnostic Role of Site of Metastasis in Predicting Outcomes in Cancer Patients Treated with Immunotherapy
2020
·
Andrea Botticelli
, Alessio Cirillo
, et al.
·
Vaccines
·
69
PDF
The Role of Soluble LAG3 and Soluble Immune Checkpoints Profile in Advanced Head and Neck Cancer: A Pilot Study
2021
·
Andrea Botticelli
, Ilaria Grazia Zizzari
, et al.
·
Journal of Personalized Medicine
·
63
PDF
Follow-up program in head and neck cancer
2017
·
Francesca De Felice
, Marco de Vincentiis
, et al.
·
Critical Reviews in Oncology/Hematology
·
63
Advances in the Management of HPV-Related Oropharyngeal Cancer
2019
·
F. De Felice
, V. Tombolini
, et al.
·
Journal of Oncology
·
57
PDF
Tryptophan Catabolism as Immune Mechanism of Primary Resistance to Anti-PD-1
2020
·
Andrea Botticelli
, Silvia Mezi
, et al.
·
Frontiers in Immunology
·
56
PDF
The role of opioids in cancer response to immunotherapy
2021
·
Andrea Botticelli
, Alessio Cirillo
, et al.
·
Journal of Translational Medicine
·
51
PDF
Involvement of the Src-cortactin pathway in migration induced by IGF-1 and EGF in human breast cancer cells
2012
·
SILVIA MEZI
, LAURA TODI
, et al.
·
International Journal of Oncology
·
42
PDF
Standard of Care and Promising New Agents for Triple Negative Metastatic Breast Cancer
2014
·
Patrizia Mancini
, Antonio Angeloni
, et al.
·
Cancers
·
36
PDF
Neuroendocrine tumors of the gallbladder: a case report and review of the literature
2011
·
Silvia Mezi
, Vincenzo Petrozza
, et al.
·
Journal of Medical Case Reports
·
31
PDF
Management of salivary gland malignant tumor: the Policlinico Umberto I, “Sapienza” University of Rome Head and Neck Unit clinical recommendations
2017
·
Francesca De Felice
, Marco de Vincentiis
, et al.
·
Critical Reviews in Oncology/Hematology
·
29
The role of immune profile in predicting outcomes in cancer patients treated with immunotherapy
2022
·
Andrea Botticelli
, Giulia Pomati
, et al.
·
Frontiers in Immunology
·
25
PDF
Tissue Immune Profile: A Tool to Predict Response to Neoadjuvant Therapy in Triple Negative Breast Cancer
2020
·
Bruna Cerbelli
, Simone Scagnoli
, et al.
·
Cancers
·
22
PDF
Clinical Multigene Panel Sequencing Identifies Distinct Mutational Association Patterns in Metastatic Colorectal Cancer
2020
·
Francesca Belardinilli
, Carlo Capalbo
, et al.
·
Frontiers in Oncology
·
22
PDF
Primary squamous cell carcinoma of major salivary gland: “Sapienza Head and Neck Unit” clinical recommendations
2020
·
Silvia Mezi
, Giulia Pomati
, et al.
·
Rare Tumors
·
21
PDF
Clinical significance of epithelial-to-mesenchymal transition in laryngeal carcinoma: Its role in the different subsites
2017
·
Silvia Mezi
, Caterina Chiappetta
, et al.
·
Head & Neck
·
20
Standard of Care and Promising New Agents for the Treatment of Mesenchymal Triple-Negative Breast Cancer
2021
·
Silvia Mezi
, Andrea Botticelli
, et al.
·
Cancers
·
18
PDF
Management of Metastatic Renal Cell Carcinoma Progressed After Sunitinib or Another Antiangiogenic Treatment
2013
·
Roberto Iacovelli
, Antonella Palazzo
, et al.
·
American Journal of Clinical Oncology
·
17
In vivo detection of resistance to anthracycline based neoadjuvant chemotherapy in locally advanced and inflammatory breast cancer with technetium-99m sestamibi scintimammography
2003
·
Silvia Mezi
, Francesca Primi
, et al.
·
International Journal of Oncology
·
17
99mTc MIBI prone scintimammography in patients with suspicious breast cancer: relationship with mammography and tumor size.
1998
·
F Scopinaro
, S Mezi
, et al.
·
International Journal of Oncology
·
17
99mTc-MIBI prone scintimammography in patients with high and intermediate risk mammography.
1997
·
F Scopinaro
, M Ierardi
, et al.
·
PubMed
·
16
Show more works
View as search
Works count:
103
Citation count:
2,444
H-index:
20
I10-index:
33
Year
Topic
Type